The $236 Billion Cliff: How Pharma Loses Its Blockbusters—and What Replaces Them
Merck made $29.5 billion from a single drug last year. That drug, Keytruda, loses its primary patent in 2028. Read […]
The $236 Billion Cliff: How Pharma Loses Its Blockbusters—and What Replaces Them Read Post »
